Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 12:02 AM ET

Healthcare Equipment and Supplies

Company Overview of Respironics Inc.

Company Overview

As of March 13, 2008, Respironics Inc. was acquired by Philips Holding USA Inc. Respironics, Inc. develops, manufactures, and distributes products for sleep and respiratory markets. It offers non-invasive ventilation systems, homecare pulse oximetry systems, oxygen concentrators, portable home ventilators, CPAP and BiPAP therapy devices, masks, diagnostic sleep systems, titration systems, screening devices, oral appliances, peak flow meters, spacer/holding chambers, nebulizers and compressors, and allergy products. The company offers its products through online. Respironics, Inc. was founded in 1976 and is headquartered in Murrysville, Pennsylvania. It has locations in Murrysville and Youngw...

1010 Murry Ridge Lane

Murrysville, PA 15668-8525

United States

Founded in 1976

4,900 Employees





Key Executives for Respironics Inc.

Respironics Inc. does not have any Key Executives recorded.

Respironics Inc. Key Developments

Respironics, Inc. Response to ResMed Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy

Respironics Inc. provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea and Chronic Heart Failure. On May 13, 2015, ResMed issued a release and a related Urgent Field Safety Notice. This report described a statistically significant 2.5% absolute increased annual risk of cardiovascular mortality for those randomized to a ResMed adaptive servo ventilation (ASV) therapy compared to the control group. In the patient population with LVEF 30 kg/66 lbs.) with obstructive sleep apnea and respiratory insufficiency caused by central and/or mixed apneas and periodic breathing. These devices are not approved or labeled for the treatment of heart failure.

Philips Respironics Announces Worldwide Recall of Approximately 600 Philips Respironics Trilogy Ventilators

Respironics Inc. announced a worldwide recall of approximately 600 Philips Respironics Trilogy Ventilators, comprising Trilogy Ventilator Models 100, 200 and 202. On February 11, 2014, Philips Respironics initiated a voluntary recall to address a potentially defective component on the Trilogy Ventilator power management board, which could affect the function of the device. If this issue is not corrected it is possible that the ventilator may fail to deliver mechanical breaths and that the alarm functionality may be reduced to indicate ventilatory failure, resulting in serious adverse health consequences or death. There have been no reports of death or serious injury related to this potential problem. The Philips Respironics Trilogy Ventilator is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation. The devices are intended to be used in home, institution/hospital, and portable applications such as wheelchairs and gurneys. During production testing Philips Respironics discovered that the Trilogy ventilators contain a potentially defective ferrite component on the power management board of the device. This recall affects 600 Trilogy Ventilator devices shipped between December 31, 2013, and January 30, 2014. Philips Respironics is instructing customers to remove affected devices from service and to return them to Philips for replacement. All distributors, providers, and customers with potentially affected Trilogy devices will have their units replaced. Philips Respironics has notified all United States and international distributors, providers, and customers that may have devices subject to this recall, and has provided affected device serial numbers for identification. Serial numbers of affected devices are located on the back of the device, as indicated in the accompanying product image. Countries where affected devices have been shipped include the United States, France, United Kingdom, Hong Kong, India, Italy, Korea, Kuwait, Netherlands, and Singapore.

Similar Private Companies By Industry

Company Name Region
Q Care International, LLC United States
GrantAdler Corporation United States
Hill-Rom Company, Inc. United States
Medical Component Specialists Inc. United States
Brooklands Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Respironics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at